Peter Wrighton-Smith, PhD
Peter is currently a Non-Exec Director of Mabtech, a Sweden-based global life science tools company and a NED of natcap, a leading provider of nature intelligence data products and services. Peter was the founder and CEO of Oxford Immunotec, a global immunology focussed in vitro diagnostics company, until 2022. Peter led Oxford Immunotec from foundation […]
Tom Hulme
Tom leads GV (Google Ventures) in Europe. GV has more than $8bn in assets under management; Tom’s investments include, Lemonade, Autolus, Snyk, Carrick Therapeutics, Currency Cloud, Multiverse, and Nothing. Previously, while leading IDEO’s startup efforts globally, he founded OpenIDEO, a platform for social good, and before that he founded his own startup. Tom’s TED talk […]
Prof. Sir Shankar Balasubramanian FRS
Sir Shankar Balasubramanian is the Herchel Smith Professor of Medicinal Chemistry at the University of Cambridge and a senior group leader at Cancer Research UK’s Cambridge Institute. He is recognised for his contributions to the chemistry, structure and function of nucleic acids. He is a co-inventor of the leading next generation DNA sequencing methodology, Solexa-Illumina […]
Peter Fromen
Mr. Fromen became the Chief Executive Officer of biomodal, formerly Cambridge Epigenetix, in 2022. Before that Mr. Fromen worked at PacBio, where he served as Chief Commercial Officer. Prior to PacBio, Mr. Fromen worked at Illumina, where he held numerous leadership positions across the finance and commercial organisations including investor relations, product marketing, market development, […]
Omead Ostadan
Mr. Ostadan was the President and Chief Operating Officer at Seer until 2022. Omead spent the previous 13 years at Illumina where he helped build Illumina’s leading position in the genomics space while serving a wide range of executive roles, culminating with his role as Chief Product and Marketing Officer. He joined Illumina in 2007 […]
Gail Marcus
Gail has been Chair of the Board of biomodal since 2022. Prior to this, Dr Marcus joined biomodal as Executive Chair in 2019. Dr Marcus is an experienced healthcare executive with leadership positions across the industry including services, diagnostics, healthcare provision, and managed care. Currently serves as a director of Natera and Triple-S Management. Previously […]
